Barbara Obermayer-Pietsch

Prof. Dr. Barbara Obermayer-Pietsch

Department of Internal Medicine, Division of Endocrinology and Diabetology, Endocrinology Lab Platform, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
IFInes Foessl
Ines Foessl
HDHans P. Dimai
Hans P. Dimai
Barbara Obermayer-PietschBarbara Obermayer-Pietsch
Barbara Obermayer-Pietsch

11 August 2023 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
JKJ.A. Kanis
J.A. Kanis
HJH. Johansson
H. Johansson
EME.V. McCloskey
E.V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
KÅKRISTINA E ÅKESSON
KRISTINA E ÅKESSON
WLW.D. Leslie
W.D. Leslie

31 May 2022 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LVL. Vandenput
L. Vandenput
HJH. Johansson
H. Johansson
EME. V. McCloskey
E. V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
KÅKRISTINA E ÅKESSON
KRISTINA E ÅKESSON
JKJ. A. Kanis
J. A. Kanis

17 January 2024 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LVLiesbeth Vandenput
Liesbeth Vandenput
HJHelena Johansson
Helena Johansson
EMEugene V. McCloskey
Eugene V. McCloskey
Enwu LiuEnwu Liu
Enwu Liu
Marian SchiniMarian Schini
Marian Schini
JKJohn A. Kanis
John A. Kanis

1 January 2015 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
SGSimona Gaberšček
Simona Gaberšček
KZKatja Zaletel
Katja Zaletel
VSVerena Schwetz
Verena Schwetz
TPThomas Pieber
Thomas Pieber
Barbara Obermayer-PietschBarbara Obermayer-Pietsch
Barbara Obermayer-Pietsch
ELElisabeth Lerchbaum
Elisabeth Lerchbaum
Thyroid disorders, especially Hashimoto's thyroiditis (HT), and polycystic ovary syndrome (PCOS) are closely associated, based on a number of studies showing a significantly higher prevalence of HT in women with PCOS than in controls. However, the mechanisms of this association are not as clear. Certainly, genetic susceptibility contributes an important part to the development of HT and PCOS. However, a common genetic background has not yet been established. Polymorphisms of the PCOS-related gene for fibrillin 3 (FBN3) could be involved in the pathogenesis of HT and PCOS. Fibrillins influence the activity of transforming growth factor beta (TGFβ). Multifunctional TGFβ is also a key regulator of immune tolerance by stimulating regulatory T cells (Tregs), which are known to inhibit excessive immune response. With lower TGFβ and Treg levels, the autoimmune processes, well known in HT and assumed in PCOS, might develop. In fact, lower levels of TGFβ1 were found in HT as well as in PCOS women carrying allele 8 of D19S884 in the FBN3 gene. Additionally, vitamin D deficiency was shown to decrease Tregs. Finally, high estrogen-to-progesterone ratio owing to anovulatory cycles in PCOS women could enhance the immune response. Harmful metabolic and reproductive effects were shown to be more pronounced in women with HT and PCOS when compared with women with HT alone or with controls. In conclusion, HT and PCOS are associated not only with respect to their prevalence, but also with regard to etiology and clinical consequences. However, a possible crosstalk of this association is yet to be elucidated.

1 May 2013 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
OTOlivia Trummer
Olivia Trummer
Stefan PilzStefan Pilz
Stefan Pilz
MHMichael M Hoffmann
Michael M Hoffmann
BWBernhard R Winkelmann
Bernhard R Winkelmann
BBBernhard O Boehm
Bernhard O Boehm
WRWilfried Renner
Wilfried Renner
BACKGROUND: Decreased circulating 25-hydroxy-vitamin D (25-OH-vitamin D) concentrations have been associated with mortality rates, but it is unclear whether this association is causal. We performed a Mendelian randomization study and analyzed whether 3 common single-nucleotide polymorphisms (SNPs) associated with 25-OH-vitamin D concentrations are causal for mortality rates. METHODS: Genotypes of SNPs in the group-specific component gene (GC, rs2282679), 7-dehydrocholesterol reductase gene (DHCR7, rs12785878), and cytochrome P450 IIR-1 gene (CYP2R1, rs10741657) were determined in a prospective cohort study of 3316 male and female participants [mean age 62.6 (10.6) years] scheduled for coronary angiography between 1997 and 2000. 25-OH-vitamin D concentrations were determined by RIA. The main outcome measures were all-cause deaths, cardiovascular deaths, and noncardiovascular deaths. RESULTS: In a linear regression model adjusting for month of blood sampling, age, and sex, vitamin D concentrations were predicted by GC genotype (P < 0.001), CYP2R1 genotype (P = 0.068), and DHCR7 genotype (P < 0.001), with a coefficient of determination (r2) of 0.175. During a median follow-up time of 9.9 years, 955 persons (30.0%) died, including 619 deaths from cardiovascular causes. In a multivariate Cox regression adjusted for classical risk factors, GC, CYP2R1, and DHCR7 genotypes were not associated with all-cause mortality, cardiovascular mortality, or noncardiovascular mortality. CONCLUSIONS: Genetic variants associated with 25-OH-vitamin D concentrations do not predict mortality. This suggests that low 25-OH-vitamin D concentrations are associated with, but unlikely to be causal for, higher mortality rates.